Amedisys, Inc.
Amedisys, Inc. (AMED) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · AMED · as of Jun 30, 2025
Ownership Breakdown
347
Institutional Holders
▲ 18 vs Q1
$3.25B
Total Inst. Value
▲ $223.22M vs Q1
32.89M
Shares Outstanding
freeFloat 98.02%
33.01M
13F Shares Held
▲ 366,675 vs Q1
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
AMED largest shareholders · institutional ownership
Q2 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. services-home health care services | 3.35M | 10.18% | 10.18% | $329.18B | Aug 12, 2025 | ▲ 78.9K |
VANGUARD GROUP INC services-home health care services | 3.04M | 9.26% | 9.26% | $299.24B | Aug 11, 2025 | ▼ 156.1K |
PENTWATER CAPITAL MANAGEMENT LP services-home health care services | 1.72M | 5.22% | 5.22% | $168.75B | Aug 14, 2025 | ▲ 370.1K |
FIL LTD services-home health care services | 1.31M | 4.00% | 4.00% | $129.16B | Aug 14, 2025 | ▲ 433.8K |
ALPINE ASSOCIATES MANAGEMENT INC. services-home health care services | 1.10M | 3.34% | 3.34% | $107.93B | Aug 5, 2025 | ▲ 104.8K |
STATE STREET CORP services-home health care services | 1.07M | 3.25% | 3.25% | $105.04B | Aug 14, 2025 | ▲ 60.0K |
NORGES BANK services-home health care services | 902.1K | 2.75% | 2.75% | $88.76B | Aug 13, 2025 | ▲ 12.7K |
UBS GROUP AG services-home health care services | 878.9K | 2.68% | 2.68% | $86.47B | Aug 14, 2025 | ▲ 244.3K |
TIG ADVISORS, LLC services-home health care services | 856.8K | 2.61% | 2.61% | $84.30B | Aug 14, 2025 | ▲ 20.3K |
QUBE RESEARCH & TECHNOLOGIES LTD services-home health care services | 790.5K | 2.41% | 2.41% | $77.78B | Aug 14, 2025 | ▲ 169.4K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2025 vs prior quarter
Q2 2025
31
Increased
+3.65M shares3
New Positions
first time holders14
Decreased
−1.71M shares0
Sold Out
fully exitedNet shares change (top 50)
+1.94M
+3.65M / −1.71M
Net new holders
+20
3 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
AMED insider trading · insider activity
Source: SEC Form 4
6
Buy transactions
59
Sell transactions
0.10
Buy/Sell ratio
$1M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Coye Molly Joel director | Aug 14, 2025 | D-Return | 8,818 | $0.00 | $8.818 | 0 | Form 4 ↗ |
Klapstein Julie D director | Aug 14, 2025 | D-Return | 16,031 | $0.00 | $16.031 | 0 | Form 4 ↗ |
Kusserow Paul B. K. director | Aug 14, 2025 | D-Return | 621 | — | — | 0 | Form 4 ↗ |
Kusserow Paul B. K. director | Aug 14, 2025 | D-Return | 80,602 | $114.78 | $9.25M | 0 | Form 4 ↗ |
Kusserow Paul B. K. director | Aug 14, 2025 | D-Return | 439,124 | $0.00 | $439.124 | 0 | Form 4 ↗ |
Rideout Jeffrey A director | Aug 14, 2025 | D-Return | 9,335 | $0.00 | $9.335 | 0 | Form 4 ↗ |
Muscato Nick Chief Strategy Officer | Aug 14, 2025 | D-Return | 3,067 | $0.00 | $3.067 | 32.6K | Form 4 ↗ |
Muscato Nick Chief Strategy Officer | Aug 14, 2025 | D-Return | 272 | $95.76 | $26.0K | 0 | Form 4 ↗ |
Muscato Nick Chief Strategy Officer | Aug 14, 2025 | D-Return | 2,040 | $143.25 | $292.2K | 0 | Form 4 ↗ |
Muscato Nick Chief Strategy Officer | Aug 14, 2025 | D-Return | 2,876 | $91.77 | $263.9K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Amedisys, Inc. (AMED) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 1.98%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Amedisys, Inc. is BLACKROCK, INC., holding approximately 3.35 million shares — equal to 10.18% of outstanding shares — as of June 30, 2025.
A total of 347 institutional investors currently hold AMED stock, with a combined institutional value of approximately $3.25 billion as of the most recent 13F filing period.
Frequently asked questions
AMED ownershipAmedisys, Inc. (AMED) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is BLACKROCK, INC. with a 10.18% stake. Company insiders hold 1.98%. Data sourced from SEC Form 13F as of June 30, 2025.